One of the most serious threats to public health worldwide is posed by antibiotic-resistant pathogens. The World Health Organization (WHO) warns of the imminent beginning of a post-antibiotic era in which harmless infections can no longer be treated and could once again become one of the most frequent non-natural causes of death. Decades of using various antibiotics as standard therapy have greatly reduced the spectrum of effective antibacterial drugs. At the same time, the development of new drugs is being partially reduced or completely discontinued. This is due to the rapid evolution of antibiotic resistance, which makes antibacterial drugs ineffective within short time periods. For some years now, researchers have therefore attempted to develop strategies to maintain or even improve the efficacy of existing antibiotics.
* This article was originally published here
